VIP and human T cells: cell cycle and regulatory properties

Evidence level: Cell study

Research question

Can VIP influence the activity and regulatory properties of human T cells? The study focuses on cellular mechanisms of immune regulation.

Research model

Researchers studied human T cells outside the body. They examined cell cycle regulation, marker expression, and the ability to suppress responses from other T cells.

What was found?

VIP exposure was associated with cell cycle arrest and a regulatory profile, including expression of CD25, CTLA-4, and FoxP3. The treated cells also showed suppressive activity against effector T cells.

Limitations and interpretation

This was a cell study, not a treatment study involving human subjects. Marker expression and functional cell tests do not fully predict effects on the human immune system.

Original publication

Vasoactive intestinal peptide induces cell cycle arrest and regulatory functions in human T cells at multiple levels. PMID: 20231362. View the original publication on PubMed.

This summary is based on the available source description and abstract; it is not a complete systematic review.

All Peptidera products are intended solely for scientific research and laboratory use. Not for human or animal consumption, self-administration, diagnosis, or treatment.